Product Name

  • Name

    Oseltamivir

  • EINECS 1308068-626-2
  • CAS No. 196618-13-0
  • Article Data66
  • CAS DataBase
  • Density 1.08 g/cm3
  • Solubility Soluble
  • Melting Point 107-108 °C
  • Formula C16H28N2O4
  • Boiling Point 473.3 °C at 760 mmHg
  • Molecular Weight 312.409
  • Flash Point 240 °C
  • Transport Information
  • Appearance
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 196618-13-0 (Oseltamivir)
  • Hazard Symbols
  • Synonyms 1-Cyclohexene-1-carboxylicacid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, [3R-(3a,4b,5a)]-;GOP-A-Flu;GS 4104;Tamiflu-Free;Tamvir;
  • PSA 90.65000
  • LogP 2.37660

Synthetic route

ethyl (3R,4R,5S)-4-N-acetylamino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

ethyl (3R,4R,5S)-4-N-acetylamino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With 1,3-dimethylbarbituric acid; tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 50℃; for 2.21667h;88.7%
Stage #1: ethyl (3R,4R,5S)-4-N-acetylamino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate With 1,3-dimethylbarbituric acid; palladium diacetate; triphenylphosphine In ethanol at 35℃; for 2h; Inert atmosphere;
Stage #2: With phosphoric acid In acetone for 2h;
83.69%
With tetrakis(triphenylphosphine) palladium(0); 1,3-dimethylbarbituric acid
(3R,4R,5S)-ethyl 4-acetamido-5-((tert-butoxycarbonyl)amino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
367252-68-4

(3R,4R,5S)-ethyl 4-acetamido-5-((tert-butoxycarbonyl)amino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 20℃; for 4h; Inert atmosphere;92%
Stage #1: (3R,4R,5S)-ethyl 4-acetamido-5-((tert-butoxycarbonyl)amino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate With hydrogenchloride; water In ethanol at 50℃; for 1h;
Stage #2: With sodium hydrogencarbonate In water
90%
With hydrogenchloride In tetrahydrofuran; ethyl acetate for 0.05h;13.8 mg
ethyl (3R,4R,5S)-4-N-acetylamino-5-N-allylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
312904-18-0

ethyl (3R,4R,5S)-4-N-acetylamino-5-N-allylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With ethanolamine; palladium 10% on activated carbon In ethanol at 20℃; for 3h; Heating / reflux;70%
With palladium on activated charcoal; ethanolamine In ethanol for 3h; Heating;
With ethanolamine; palladium on activated charcoal In ethanol for 3h; Heating;
(1S,2R,3S,4R,5S)-4-acetylamino-3-(1-ethylpropoxy)-5-nitro-2-p-tolylsulfanylcyclohexanecarboxylic acid ethyl ester

(1S,2R,3S,4R,5S)-4-acetylamino-3-(1-ethylpropoxy)-5-nitro-2-p-tolylsulfanylcyclohexanecarboxylic acid ethyl ester

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: (1S,2R,3S,4R,5S)-4-acetylamino-3-(1-ethylpropoxy)-5-nitro-2-p-tolylsulfanylcyclohexanecarboxylic acid ethyl ester With chloro-trimethyl-silane; zinc In ethanol at 23 - 70℃; for 2h; Inert atmosphere;
Stage #2: With ammonia In ethanol at 0℃; for 0.166667h;
Stage #3: With potassium carbonate In ethanol at 23℃; for 6h;
85%
Stage #1: (1S,2R,3S,4R,5S)-4-acetylamino-3-(1-ethylpropoxy)-5-nitro-2-p-tolylsulfanylcyclohexanecarboxylic acid ethyl ester With chloro-trimethyl-silane; zinc In ethanol at 70℃; for 2h; Inert atmosphere;
Stage #2: With ammonia In ethanol at 0℃; for 0.166667h; Inert atmosphere;
Stage #3: With potassium carbonate In ethanol at 23℃; for 9h; Inert atmosphere;
81%
Stage #1: (1S,2R,3S,4R,5S)-4-acetylamino-3-(1-ethylpropoxy)-5-nitro-2-p-tolylsulfanylcyclohexanecarboxylic acid ethyl ester With chloro-trimethyl-silane; zinc In ethanol at 70℃; for 2h;
Stage #2: With ammonia; potassium carbonate In ethanol at 20℃; for 6h;
80%
(3R,4R,5S)-4-acetamido-5-(1,3-dioxoisoindol-2-yl)-3-(pentyl-3-yloxy)cyclohexyl-ethyl-1-ene-1-carboxylate
1041262-68-3

(3R,4R,5S)-4-acetamido-5-(1,3-dioxoisoindol-2-yl)-3-(pentyl-3-yloxy)cyclohexyl-ethyl-1-ene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With hydrazine In ethanol at 68℃; for 10h;100%
With hydrazine In ethanol at 68℃; for 10h; Inert atmosphere;100%
With hydrazine In ethanol at 68℃; for 11h; Schlenk technique; Inert atmosphere;86%
(3R,4R,5S)-4-acetamido-5-allyloxycarbonylamino-1-ethoxycarbonyl-3-(3-pentyloxy)cyclohex-1-ene

(3R,4R,5S)-4-acetamido-5-allyloxycarbonylamino-1-ethoxycarbonyl-3-(3-pentyloxy)cyclohex-1-ene

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With pyrrolidine; tetrakis(triphenylphosphine) palladium(0) In ethanol for 0.5h;95.1%
With 1,3-dimethylbarbituric acid; triphenylphosphine; palladium on activated charcoal In ethanol; water at 80℃; for 1h;
(3R,4R,5S)-ethyl-4-(N-acetylacetamide)-5-(1,3-dioxoisoindolin-2-yl)-3-(3-pentyloxy)cyclohex-1-ene carboxylate
1197396-47-6

(3R,4R,5S)-ethyl-4-(N-acetylacetamide)-5-(1,3-dioxoisoindolin-2-yl)-3-(3-pentyloxy)cyclohex-1-ene carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: (3R,4R,5S)-ethyl-4-(N-acetylacetamide)-5-(1,3-dioxoisoindolin-2-yl)-3-(3-pentyloxy)cyclohex-1-ene carboxylate With hydrazine hydrate In ethanol at 50℃; for 14h; Inert atmosphere;
Stage #2: With hydrogenchloride; water In ethanol
Stage #3: With ammonium hydroxide In water pH=11;
96%
C21H36N2O6

C21H36N2O6

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With trifluoroacetic acid In isopropyl alcohol at 0 - 30℃; for 7h; Solvent; Reagent/catalyst; Temperature;96%
oseltamivir
204255-06-1

oseltamivir

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With hydrogen at 20℃; under 380.026 Torr; for 3h;98.5%
With tributylphosphine; acetic acid In ethanol; water at 5 - 25℃; for 5.5 - 9h;97%
With triphenylphosphine In tetrahydrofuran; water at 50℃; for 10h;96%
(1S,2R,3S,4R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)-2-(p-tolylthio)cyclohexanecarboxylate

(1S,2R,3S,4R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)-2-(p-tolylthio)cyclohexanecarboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With potassium carbonate In ethanol at 23℃; for 4h; retro Michael reaction;91%
With potassium carbonate In ethanol at 23℃; for 4h; Product distribution / selectivity;91%
Stage #1: (1S,2R,3S,4R,5S)-ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)-2-(p-tolylthio)cyclohexanecarboxylate With ammonia In ethanol at 0℃; for 0.166667h; Inert atmosphere;
Stage #2: With potassium carbonate In ethanol at 23℃; for 6h; Inert atmosphere;
45.2 mg
oseltamivir phosphate
204255-11-8

oseltamivir phosphate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With sodium hydrogencarbonate In water at 20℃; for 0.0833333h; Inert atmosphere;98%
Stage #1: oseltamivir phosphate In dichloromethane; water at 25 - 30℃; for 0.166667h;
Stage #2: With ammonia In dichloromethane; water pH=9 - 10;
Stage #3: In n-heptane at 25 - 30℃; for 1h; Purification / work up;
Stage #1: oseltamivir phosphate In dichloromethane; water at 25 - 30℃; for 0.166667h;
Stage #2: With ammonia In dichloromethane; water pH=9 - 10;
Stage #3: In n-heptane; toluene at 20 - 30℃; for 3.5h; Purification / work up;
In dichloromethane; water at 20℃; for 0.75h;
ethyl (3R,4R,5S)-4-N-acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
651324-07-1

ethyl (3R,4R,5S)-4-N-acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogenchloride / water; ethanol / 13 - 25 °C
2: trifluoroacetic acid / 1.5 h / 50 °C
3: 1,3-dimethylbarbituric acid; triphenylphosphine; palladium diacetate / ethanol / 2 h / 35 °C / Sealed tube; Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: trifluoroacetic acid / dichloromethane / 1 h / 50 °C
2: 1,3-dimethylbarbituric acid; palladium diacetate; triphenylphosphine / ethanol / 2 h / 20 - 25 °C / Inert atmosphere
View Scheme
Multi-step reaction with 2 steps
1: 1,3-dimethylbarbituric acid; palladium diacetate; triphenylphosphine / ethanol / 2 h / 20 - 25 °C / Inert atmosphere
2: trifluoroacetic acid / dichloromethane / 2 h / 35 - 40 °C
View Scheme
With 1,3-dimethylbarbituric acid; palladium diacetate; triphenylphosphine In ethanol; water at 50℃;
C20H36N2O4

C20H36N2O4

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane at 35 - 40℃; for 2h;
With trifluoroacetic acid In dichloromethane at 50℃; for 2h; Reagent/catalyst; Solvent;
tert-butyl [(1S,5R,6R)-6-acetylamino-3-cyano-5-(1-ethylpropoxy)cyclohex-3-en-1-yl]carbamate
891831-22-4

tert-butyl [(1S,5R,6R)-6-acetylamino-3-cyano-5-(1-ethylpropoxy)cyclohex-3-en-1-yl]carbamate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: tert-butyl [(1S,5R,6R)-6-acetylamino-3-cyano-5-(1-ethylpropoxy)cyclohex-3-en-1-yl]carbamate With hydrogenchloride In ethanol at 60℃; for 4h;
Stage #2: With water In ethanol at 4℃; for 3h;
53%
(3R,4R)-ethyl 4-acetamido-5-nitro-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

(3R,4R)-ethyl 4-acetamido-5-nitro-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

A

ethyl (3R,4R,5R)-4-acetylamino-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
1402431-91-7

ethyl (3R,4R,5R)-4-acetylamino-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate

B

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With chloro-trimethyl-silane; ethanol; zinc In tetrahydrofuran; toluene at 70℃; for 2h; Flow reactor;A n/a
B n/a
C19H35N2O4P
1362750-80-8

C19H35N2O4P

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: C19H35N2O4P With hydrogenchloride; water In dichloromethane; toluene at 20℃; for 4h;
Stage #2: With sodium hydrogencarbonate In dichloromethane; water; toluene pH=10;
53.2 mg
(3R,4R,5S)-ethyl 4-acetylamino-3-(pentan-3-yloxy)-5-(2,2,2-trichloroacetamido)cyclohex-1-enecarboxylate
1443055-49-9

(3R,4R,5S)-ethyl 4-acetylamino-3-(pentan-3-yloxy)-5-(2,2,2-trichloroacetamido)cyclohex-1-enecarboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: (3R,4R,5S)-ethyl 4-acetylamino-3-(pentan-3-yloxy)-5-(2,2,2-trichloroacetamido)cyclohex-1-enecarboxylate With caesium carbonate In dimethyl sulfoxide at 80℃; for 0.25h;
Stage #2: With acetic acid In water; dimethyl sulfoxide at 80℃; for 0.333333h;
ethyl (3R,4R,5S)-4-acetamido-5-nitro-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate
949164-64-1

ethyl (3R,4R,5S)-4-acetamido-5-nitro-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With acetic acid; zinc at 20℃; for 34h; Inert atmosphere;81%
Stage #1: ethyl (3R,4R,5S)-4-acetamido-5-nitro-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate With acetic acid; zinc In ethanol at 70℃; Inert atmosphere; Reflux;
Stage #2: With ammonium hydroxide In ethanol; water at 20℃; pH=8; Inert atmosphere;
71%
With hydrogenchloride In water at 50℃; for 1h; Inert atmosphere;
With chloro-trimethyl-silane; acetic acid; zinc In diethyl ether for 8h; Reflux;
(3R,4R,5S)-4-acetylamino-5-benzyloxycarbonylamino-1-cyano-3-(1-ethylpropoxy)cyclohexene
927395-63-9

(3R,4R,5S)-4-acetylamino-5-benzyloxycarbonylamino-1-cyano-3-(1-ethylpropoxy)cyclohexene

ethanol
64-17-5

ethanol

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: (3R,4R,5S)-4-acetylamino-5-benzyloxycarbonylamino-1-cyano-3-(1-ethylpropoxy)cyclohexene; ethanol With hydrogenchloride at 20℃; for 24h;
Stage #2: With water In ethanol at 20℃; for 2h;
Stage #3: With ammonium hydroxide In ethanol at 20℃; for 10h;
74%
ethyl (3R,4R,5R,6R)-4-acetamido-5-azido-6-(methylsulfonyloxy)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
1196490-17-1

ethyl (3R,4R,5R,6R)-4-acetamido-5-azido-6-(methylsulfonyloxy)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

A

C16H27NO4
1196490-21-7

C16H27NO4

B

ethyl (3S,4R,5R)-4-acetamido-3-amino-5-(pentan-3-yloxy)-cyclohex-1-enecarboxylate
1052063-39-4

ethyl (3S,4R,5R)-4-acetamido-3-amino-5-(pentan-3-yloxy)-cyclohex-1-enecarboxylate

C

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With sodium tetrahydroborate In tetrahydrofuran; ethanol at -30 - 20℃;
(1S,5R,6S)-5-(pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid ethyl ester
204254-96-6

(1S,5R,6S)-5-(pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylic acid ethyl ester

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1.1: 97 percent / MgBr2*OEt2 / acetonitrile; various solvent(s) / 16 h / 55 °C
2.1: ethanolamine; Pd/C / ethanol / 3 h / Heating
2.2: 77 percent / H2SO4
3.1: various solvent(s)
4.1: Et3N / various solvent(s)
5.1: various solvent(s) / 15 h / 111 - 112 °C / 2625.21 - 3375.27 Torr
6.1: AcOH; MeSO3H / various solvent(s) / 15 h / 20 °C
7.1: NH2CH2CH2OH; Pd/C / ethanol / 3 h / Heating
View Scheme
Multi-step reaction with 7 steps
1.1: MgBr2*OEt2 / acetonitrile; various solvent(s) / Heating
1.2: H2NCH2CH2OH / Pd/C / ethanol / 3 h / Heating
2.1: 6 h / 100 °C / 750.08 - 3750.38 Torr
3.1: Et3N / ethyl acetate / 0 - 20 °C
4.1: MeSO3H / ethanol / 2.67 h / Heating
5.1: ethyl acetate / 6 h / 112 °C / 750.08 - 4500.45 Torr
6.1: AcOH; MeSO3H / various solvent(s) / 0 - 20 °C
7.1: H2NCH2CH2OH / Pd/C / ethanol / 3 h / Heating
View Scheme
Multi-step reaction with 7 steps
1.1: MgBr2*OEt2 / acetonitrile; various solvent(s) / Heating
1.2: H2NCH2CH2OH / Pd/C / ethanol / 3 h / Heating
2.1: 6 h / 100 °C / 750.08 - 3750.38 Torr
3.1: Et3N / ethyl acetate / 0 - 20 °C
4.1: MeSO3H / ethanol / 2.67 h / Heating
5.1: ethyl acetate / 6 h / 112 °C / 750.08 - 4500.45 Torr
6.1: AcOH; MeSO3H / various solvent(s) / 0 - 20 °C
7.1: HOCH2CH2OH / Pd/C / ethanol / Heating
View Scheme
ethyl (3R,4S,5R)-5-amino-3-(1-ethylpropoxy)-4-hydroxy-1-cyclohexene-1-carboxylate
312904-12-4

ethyl (3R,4S,5R)-5-amino-3-(1-ethylpropoxy)-4-hydroxy-1-cyclohexene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: various solvent(s)
2: Et3N / various solvent(s)
3: various solvent(s) / 15 h / 111 - 112 °C / 2625.21 - 3375.27 Torr
4: AcOH; MeSO3H / various solvent(s) / 15 h / 20 °C
5: NH2CH2CH2OH; Pd/C / ethanol / 3 h / Heating
View Scheme
Multi-step reaction with 6 steps
1: 6 h / 100 °C / 750.08 - 3750.38 Torr
2: Et3N / ethyl acetate / 0 - 20 °C
3: MeSO3H / ethanol / 2.67 h / Heating
4: ethyl acetate / 6 h / 112 °C / 750.08 - 4500.45 Torr
5: AcOH; MeSO3H / various solvent(s) / 0 - 20 °C
6: H2NCH2CH2OH / Pd/C / ethanol / 3 h / Heating
View Scheme
Multi-step reaction with 6 steps
1: 6 h / 100 °C / 750.08 - 3750.38 Torr
2: Et3N / ethyl acetate / 0 - 20 °C
3: MeSO3H / ethanol / 2.67 h / Heating
4: ethyl acetate / 6 h / 112 °C / 750.08 - 4500.45 Torr
5: AcOH; MeSO3H / various solvent(s) / 0 - 20 °C
6: HOCH2CH2OH / Pd/C / ethanol / Heating
View Scheme
Multi-step reaction with 6 steps
1: acetonitrile / 1 h / 35 °C
2: pyridine / chloroform / 3 h / -5 °C
3: pyridine / tert-butyl methyl ether / 10 h / 80 °C
4: hydrogen; palladium on activated charcoal / ethanol / 8 h / 35 °C / 760.05 Torr
5: tert-butyl methyl ether / 2 h / 40 °C
6: trifluoroacetic acid / isopropyl alcohol / 7 h / 0 - 30 °C
View Scheme
2-pentanol
584-02-1

2-pentanol

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: BF3*Et2O / 2 h / 70 - 75 °C
2: pyridine, (dimethylamino)pyridine / 18 h / Ambient temperature
3: Ph3P, H2O / tetrahydrofuran / 10 h / 50 °C
View Scheme
Multi-step reaction with 4 steps
1: boron trifluoride diethyl etherate / 75 °C / Inert atmosphere
2: pyridine; dmap / 1 h / 150 °C / Inert atmosphere; Microwave irradiation
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.5 h / 20 °C / Inert atmosphere
4: hydrazine / ethanol / 10 h / 68 °C / Inert atmosphere
View Scheme
Multi-step reaction with 4 steps
1: boron trifluoride diethyl etherate / 75 °C / Inert atmosphere
2: pyridine; dmap / 1 h / 150 °C / Inert atmosphere; Microwave irradiation
3: tetrabutyl ammonium fluoride / tetrahydrofuran / 0.5 h / 20 °C / Inert atmosphere
4: hydrazine / ethanol / 10 h / 68 °C / Inert atmosphere
View Scheme
C24H34N2O6
1158724-89-0

C24H34N2O6

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane; ethanol at 20℃; for 24h;83%
2-(1-ethylpropoxy)acetaldehyde
1141364-90-0

2-(1-ethylpropoxy)acetaldehyde

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1.1: (R)-2-(diphenyl(trimethylsilyloxy)methyl)pyrrolidine; chloroacetic acid / toluene
2.1: caesium carbonate / 4 h / 0 - 20 °C
3.1: -15 °C
4.1: trifluoroacetic acid / toluene / 4 h / 20 °C
5.1: oxalyl dichloride; N,N-dimethyl-formamide / toluene / 0.33 h / 20 °C
6.1: trimethylsilylazide / toluene / 0.33 h / 20 °C
7.1: acetic acid / 48 h / 20 °C
8.1: chloro-trimethyl-silane; zinc / ethanol / 70 °C
8.2: 0 °C
9.1: potassium carbonate / 20 °C
View Scheme
Multi-step reaction with 5 steps
1.1: (R)-2-(diphenyl(trimethylsilyloxy)methyl)pyrrolidine; chloroacetic acid / toluene / 6 h / 23 °C / Inert atmosphere
1.2: 2 h / 23 °C / Inert atmosphere
2.1: trifluoroacetic acid / toluene / 4 h / 23 °C / Inert atmosphere
3.1: oxalyl dichloride; N,N-dimethyl-formamide / toluene / 0.5 h / 23 °C / Inert atmosphere
4.1: pyridine; trimethylsilylazide / N,N-dimethyl-formamide / 20 °C / Microflow reaction; Inert atmosphere
4.2: 110 °C / Microflow reaction; Inert atmosphere
5.1: chloro-trimethyl-silane; zinc / ethanol / 2 h / 70 °C / Inert atmosphere
5.2: 0.17 h / 0 °C / Inert atmosphere
5.3: 9 h / 23 °C / Inert atmosphere
View Scheme
Multi-step reaction with 3 steps
1: (2S)-2-{diphenyl[(trimethylsilyl)oxy]methyl}pyrrolidine; chloroacetic acid / dimethyl sulfoxide / 20 °C
2: 1,8-diazabicyclo[5.4.0]undec-7-ene; lithium chloride / acetonitrile / 70 °C / Inert atmosphere
3: acetic acid; zinc / 34 h / 20 °C / Inert atmosphere
View Scheme
N-((2R,3S)-1-nitro-4-oxo-3-(pentan-3-yloxy)butan-2-yl)acetamide
1226768-14-4

N-((2R,3S)-1-nitro-4-oxo-3-(pentan-3-yloxy)butan-2-yl)acetamide

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: caesium carbonate / 3 h / 0 °C
2: 36 h / -15 °C
3: chloro-trimethyl-silane; zinc / 2 h / -15 - 70 °C
4: ammonia; potassium carbonate / 14 h / 20 °C
View Scheme
Multi-step reaction with 4 steps
1.1: caesium carbonate / 3 h / 0 °C
1.2: 1 h
2.1: 36 h / -15 °C
3.1: chloro-trimethyl-silane; zinc / 2 h / -15 - 70 °C
4.1: ammonia; potassium carbonate / 14 h / 20 °C
View Scheme
Multi-step reaction with 5 steps
1: potassium carbonate / acetonitrile / 3 h / 0 - 20 °C
2: zinc; acetic acid / ethanol / 0.5 h / 70 °C / Inert atmosphere
3: acetonitrile / 4 h / 20 °C
4: lithium chloride / dimethyl sulfoxide / 2 h / 190 °C / Inert atmosphere
5: trifluoroacetic acid / dichloromethane / 4 h / 20 °C / Inert atmosphere
View Scheme
tert-butyl [(1S,5R,6R)-6-acetylamino-3-cyano-5-(1-ethylpropoxy)cyclohex-3-en-1-yl]carbamate
891831-22-4

tert-butyl [(1S,5R,6R)-6-acetylamino-3-cyano-5-(1-ethylpropoxy)cyclohex-3-en-1-yl]carbamate

ethanol
64-17-5

ethanol

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Stage #1: tert-butyl [(1S,5R,6R)-6-acetylamino-3-cyano-5-(1-ethylpropoxy)cyclohex-3-en-1-yl]carbamate; ethanol With hydrogenchloride at 20℃; for 24h;
Stage #2: With water at 4 - 20℃; for 7.5h;
60%
ethyl (3R,4R,5S)-5-N-allylamino-4-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
312904-15-7

ethyl (3R,4R,5S)-5-N-allylamino-4-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: AcOH; MeSO3H / various solvent(s) / 15 h / 20 °C
2: NH2CH2CH2OH; Pd/C / ethanol / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: AcOH; MeSO3H / various solvent(s) / 0 - 20 °C
2: H2NCH2CH2OH / Pd/C / ethanol / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: AcOH; MeSO3H / various solvent(s) / 0 - 20 °C
2: HOCH2CH2OH / Pd/C / ethanol / Heating
View Scheme
argon

argon

sodium hydrogencarbonate
144-55-8

sodium hydrogencarbonate

1-amino-2-propene
107-11-9

1-amino-2-propene

A

oseltamivir
196618-13-0

oseltamivir

B

ethyl (3R,4R,5S)-5-N-allylamino-4-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate
312904-15-7

ethyl (3R,4R,5S)-5-N-allylamino-4-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

Conditions
ConditionsYield
With sodium sulfate In ethyl acetate
(3R,4S,5R)-4-acetylamino-3-(1-ethyl-propoxy)-5-methanesulfonyloxy-cyclohex-1-enecarboxylic acid ethyl ester
1132659-99-4

(3R,4S,5R)-4-acetylamino-3-(1-ethyl-propoxy)-5-methanesulfonyloxy-cyclohex-1-enecarboxylic acid ethyl ester

oseltamivir
196618-13-0

oseltamivir

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium azide / N,N-dimethyl-formamide / 8 h / 90 °C
2: water; triphenylphosphine / tetrahydrofuran / 8 h / Reflux
View Scheme
Multi-step reaction with 2 steps
1: sodium azide / N,N-dimethyl-formamide / 3 h / 80 °C
2: hydrogen / ethanol / 20 °C
View Scheme
Multi-step reaction with 2 steps
1.1: sodium azide / ethanol; water / 8 h / Reflux
2.1: triphenylphosphine / tetrahydrofuran / 4 h / 20 °C
2.2: Staudinger Azide Reduction / 24 h / 20 °C
View Scheme
1,3-di(tert-butyloxycarbonyl)-2-(trifluoromethylsulfonyl)guanidine
207857-15-6

1,3-di(tert-butyloxycarbonyl)-2-(trifluoromethylsulfonyl)guanidine

oseltamivir
196618-13-0

oseltamivir

(3R,4R,5S)-5-[[(1Z)-[[(tert-butoxy)carbonyl]amino]([[(tert-butoxy)carbonyl]imino])methyl]amino]-4-acetylamino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid ethyl ester
208720-81-4

(3R,4R,5S)-5-[[(1Z)-[[(tert-butoxy)carbonyl]amino]([[(tert-butoxy)carbonyl]imino])methyl]amino]-4-acetylamino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In dichloromethane100%
oseltamivir
196618-13-0

oseltamivir

oseltamivir acid

oseltamivir acid

Conditions
ConditionsYield
With sodium hydroxide In ethanol at 90℃; for 2h;99%
Stage #1: oseltamivir With potassium hydroxide; water In tetrahydrofuran at 0 - 20℃; for 1h;
Stage #2: With Amberlite IR-120 In tetrahydrofuran pH=5;
88%
Stage #1: oseltamivir With potassium hydroxide In methanol; water
Stage #2: In methanol; water for 0.0833333h;
79%
oseltamivir
196618-13-0

oseltamivir

oseltamivir
204255-06-1

oseltamivir

Conditions
ConditionsYield
With fluorosulfonyl azide; potassium hydrogencarbonate In tert-butyl methyl ether; water; N,N-dimethyl-formamide at 20℃; for 0.5h;99%
oseltamivir
196618-13-0

oseltamivir

oseltamivir phosphate
204255-11-8

oseltamivir phosphate

Conditions
ConditionsYield
With phosphoric acid In ethanol at 50℃; for 0.0166667h; Sonication;98%
With phosphoric acid In ethanol at -18.8℃; for 17h;89.9%
With phosphoric acid In ethanol at 50 - 55℃;88.6%
2,2,2-trifluoroethanol
75-89-8

2,2,2-trifluoroethanol

oseltamivir
196618-13-0

oseltamivir

(3R,4R,5S)-4-acetylamino-5-trifluoroacetylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester

(3R,4R,5S)-4-acetylamino-5-trifluoroacetylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
With copper(l) iodide; 9-azabicyclo<3.3.1>nonane-N-oxyl; oxygen; 4,4'-di-tert-butyl-2,2'-bipyridine In acetonitrile at 20℃; under 760.051 Torr; for 4h; Sealed tube;90%
tert-butyl N-({[(tert-butoxy)carbonyl]amino}methanethioyl)carbamate
145013-05-4

tert-butyl N-({[(tert-butoxy)carbonyl]amino}methanethioyl)carbamate

oseltamivir
196618-13-0

oseltamivir

ethyl (3R,4R,5S)-4-acetamido-5-[N2,N3-bis(tert-butoxycarbonyl)guanidino]-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

ethyl (3R,4R,5S)-4-acetamido-5-[N2,N3-bis(tert-butoxycarbonyl)guanidino]-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate

Conditions
ConditionsYield
With triethylamine; mercury dichloride In N,N-dimethyl-formamide at 0℃;89%
With triethylamine In N,N-dimethyl-formamide at 0 - 20℃;89%
With triethylamine; mercury dichloride In N,N-dimethyl-formamide at 20℃; for 10h;177 mg
phosphoric acid
86119-84-8, 7664-38-2

phosphoric acid

oseltamivir
196618-13-0

oseltamivir

oseltamivir phosphate
204255-11-8

oseltamivir phosphate

Conditions
ConditionsYield
In ethanol; water at 50 - 55℃; for 1.5 - 2h;88%
2,6-dimethyl-1,4-dihydropyridine-3,4,5-tricarboxylic acid 3,5-diethyl ester
19350-66-4

2,6-dimethyl-1,4-dihydropyridine-3,4,5-tricarboxylic acid 3,5-diethyl ester

oseltamivir
196618-13-0

oseltamivir

diethyl 4-(((1S,5R,6R)-6-acetamido-3-(ethoxycarbonyl)-5-(pentan-3-yloxy)cyclohex-3-en-1-yl)carbamoyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

diethyl 4-(((1S,5R,6R)-6-acetamido-3-(ethoxycarbonyl)-5-(pentan-3-yloxy)cyclohex-3-en-1-yl)carbamoyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

Conditions
ConditionsYield
Stage #1: 2,6-dimethyl-1,4-dihydropyridine-3,4,5-tricarboxylic acid 3,5-diethyl ester With triethylamine; isobutyl chloroformate In dichloromethane at 0 - 20℃; for 0.5h; Inert atmosphere;
Stage #2: oseltamivir In dichloromethane at 20℃; Inert atmosphere;
87%
tert-butyldicarbonate
34619-03-9

tert-butyldicarbonate

oseltamivir
196618-13-0

oseltamivir

(3R,4R,5S)-ethyl 4-acetamido-5-((tert-butoxycarbonyl)amino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate
367252-68-4

(3R,4R,5S)-ethyl 4-acetamido-5-((tert-butoxycarbonyl)amino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate

Conditions
ConditionsYield
With triethylamine In methanol at 0 - 20℃; for 18h;86%
With triethylamine In methanol at 0 - 20℃; for 18h;86%
5-bromo-2-chloro-3-nitropyridine
67443-38-3

5-bromo-2-chloro-3-nitropyridine

oseltamivir
196618-13-0

oseltamivir

(3R,4R,5S)-4-acetamido-5-[2-(5-bromo-3-nitro)pyridinylamino]-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester

(3R,4R,5S)-4-acetamido-5-[2-(5-bromo-3-nitro)pyridinylamino]-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 60℃;82%
oseltamivir
196618-13-0

oseltamivir

C16H28N2O4*H3O4P

C16H28N2O4*H3O4P

Conditions
ConditionsYield
With phosphoric acid In ethanol; water at 65 - 75℃; for 8h; pH=4; Temperature; pH-value;81.9%
methanesulfonyl chloride
124-63-0

methanesulfonyl chloride

oseltamivir
196618-13-0

oseltamivir

C17H30N2O6S

C17H30N2O6S

Conditions
ConditionsYield
With triethylamine In dichloromethane at 20℃; for 2h;80%
With triethylamine In dichloromethane at 0℃;
hexyloxycarbonyl isothiocyanate

hexyloxycarbonyl isothiocyanate

oseltamivir
196618-13-0

oseltamivir

(3R,4R,5S)-4-acetamido-5-[N-(N′-n-hexyloxycarbonyl)thioureido]-3-(1-ethylpropoxy)-cyclohex-1-en-1-carboxylic acid ethyl ester

(3R,4R,5S)-4-acetamido-5-[N-(N′-n-hexyloxycarbonyl)thioureido]-3-(1-ethylpropoxy)-cyclohex-1-en-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
In dichloromethane at 20℃; for 2h;75%
acetic acid
64-19-7

acetic acid

oseltamivir
196618-13-0

oseltamivir

(3R,4R,5S)-4-acetylamino-5-acetylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester
1191921-01-3

(3R,4R,5S)-4-acetylamino-5-acetylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid ethyl ester

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate at 20℃;74.5%
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In dichloromethane at 20℃;

Oseltamivir Specification

The 1-Cyclohexene-1-carboxylicacid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- , with cas register number of 196618-13-0, belongs to the classification codes of (1)anti-infective agents ; (2)antiviral agents ; (3)enzyme inhibitors ; (4)influenza treatment. It also has other names such as Oseltamivir ; Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate . Its IUPAC name is ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate . And its systematic name is also called ethyl (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate .

Physical properties of 1-Cyclohexene-1-carboxylicacid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- are: (1) ACD/LogP: 1.50 ; (2)# of Rule of 5 Violations: 0 ; (3)ACD/LogD (pH 5.5): -1.02 ; (4) ACD/LogD (pH 7.4): 0.69 ; (5) ACD/BCF (pH 5.5): 1 ; (6) ACD/BCF (pH 7.4): 1.25 ; (7) ACD/KOC (pH 5.5): 1 ; (8) ACD/KOC (pH 7.4): 24.06 ; (9) #H bond acceptors: 6 ; (10) #H bond donors: 3 ; (11) #Freely Rotating Bonds: 9 ; (12) Index of Refraction: 1.502 ; (13) Molar Refractivity: 84.66 cm3 ; (14) Molar Volume: 286.7 cm3 ; (15) Surface Tension: 41.1 dyne/cm ; (16) Density: 1.08 g/cm3 ; (17) Flash Point: 240 °C ; (18) Enthalpy of Vaporization: 73.64 kJ/mol ; (19) Boiling Point: 473.3 °C at 760 mmHg ; (20) Vapour Pressure: 3.98E-09 mmHg at 25°C.

Uses of 1-Cyclohexene-1-carboxylicacid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- : This compound is an acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits neuraminidase. It has been used as a drug for treatment of influenza.

You can still convert the following datas into molecular structure:
(1) SMILES:O=C(OCC)/C1=C/[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1;
(2) InChI:InChI=1/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1;
(3) InChIKey:VSZGPKBBMSAYNT-RRFJBIMHBB

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View